FASEB J. Pierce now sold as Thermo Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/3/550
05-4654fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumoto, S. C.
Right arrow Articles by Paveto, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumoto, S. C.
Right arrow Articles by Paveto, C.
The FASEB Journal Express Article doi:10.1096/fj.05-4654fje
Published online January 19, 2006

Retinal dysfunction in patients with chronic Chagas' disease is associated to anti-Trypanosoma cruzi antibodies that cross-react with rhodopsin

Silvia C. Matsumoto, Vivian Labovsky, Marcela Roncoroni, María C. Guida, Luisa Giménez, Jorge Mitelman, Horacio Gori, Renata Jurgelevicius, Alejandro Grillo, Pablo Manfredi, Mariano J. Levin, and Cristina Paveto

E-mail contact: cpaveto{at}dna.uba.ar

To investigate retinal involvement in chronic Chagas' disease, we performed electroretinography and retinal fluorescein angiography studies in chagasic patients. Our results demonstrated a dissociated electrophysiological response characterized by both an abnormal reduction of the electroretinographic b-wave amplitude and a delayed latency, under the dark-adaptated condition. These alterations are compatible with a selective dysfunction of the rods. Antibodies raised against Trypanosoma cruzi that also interact with β1-adrenergic receptor blocked light stimulation of cGMP-phosphodiesterase in bovine rod membranes. The specificity from the antibody-rhodopsin interaction was confirmed by Western blot analysis and antigenic competition experiments. Our results suggest an immunomediated rhodopsin blockade. T. cruzi infection probably induces an autoimmune response against rhodopsin in the chronic phase of Chagas' disease through a molecular mimicry mechanism similar to that described previously on cardiac human β1-adrenergic and M2-cholinergic receptors, all related to the same subfamily of G-protein-coupled receptors.

Key words: electroretinography • rod dysfunction




This article has been cited by other articles:


Home page
J. Exp. Med.Home page
A. W. Ashton, S. Mukherjee, F. Nagajyothi, H. Huang, V. L. Braunstein, M. S. Desruisseaux, S. M. Factor, L. Lopez, J. W. Berman, M. Wittner, et al.
Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection
J. Exp. Med., April 9, 2007; (2007) jem.20062432.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. Smulski, V. Labovsky, G. Levy, M. Hontebeyrie, J. Hoebeke, and M. J. Levin
Structural basis of the cross-reaction between an antibody to the Trypanosoma cruzi ribosomal P2{beta} protein and the human {beta}1 adrenergic receptor
FASEB J, July 1, 2006; 20(9): 1396 - 1406.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by The Federation of American Societies for Experimental Biology.